Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
107.5 USD | +0.63% | +0.23% | -2.31% |
Apr. 26 | Dexcom's profit beats estimates on strong glucose monitor demand | RE |
Apr. 26 | Edwards Lifesciences first-quarter profit beats estimates on heart devices strength | RE |
Financials (USD)
Sales 2024 * | 41.7B | Sales 2025 * | 44.75B | Capitalization | 187B |
---|---|---|---|---|---|
Net income 2024 * | 5.96B | Net income 2025 * | 7.17B | EV / Sales 2024 * | 4.61 x |
Net Debt 2024 * | 5.47B | Net cash position 2025 * | 913M | EV / Sales 2025 * | 4.15 x |
P/E ratio 2024 * |
31.4
x | P/E ratio 2025 * |
26.8
x | Employees | 114,000 |
Yield 2024 * |
2.01% | Yield 2025 * |
2.15% | Free-Float | 86.77% |
Latest transcript on Abbott Laboratories
1 day | +0.63% | ||
1 week | +0.23% | ||
Current month | -5.39% | ||
1 month | -3.56% | ||
3 months | -4.00% | ||
6 months | +14.42% | ||
Current year | -2.31% |
Managers | Title | Age | Since |
---|---|---|---|
Robert Ford
CEO | Chief Executive Officer | 50 | 14-12-31 |
Philip Boudreau
DFI | Director of Finance/CFO | 51 | 96-12-31 |
Scott House
CTO | Chief Tech/Sci/R&D Officer | - | 89-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Daniel Starks
BRD | Director/Board Member | 69 | 17-02-15 |
John Stratton
BRD | Director/Board Member | 63 | 17-06-28 |
Nancy McKinstry
BRD | Director/Board Member | 65 | 11-12-08 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
7.18% | 18 M€ | +3.79% | - | |
5.19% | 2 M€ | -.--% | ||
3.00% | 2 M€ | -.--% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 107.5 | +0.63% | 3,575,566 |
24-04-25 | 106.9 | -0.03% | 3,112,495 |
24-04-24 | 106.9 | -0.65% | 5,052,691 |
24-04-23 | 107.6 | +0.49% | 3,849,589 |
24-04-22 | 107.1 | -0.20% | 4,948,315 |
Delayed Quote Nyse, April 26, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-2.31% | 187B | |
-3.20% | 106B | |
-5.04% | 66.9B | |
+0.20% | 49.45B | |
+17.29% | 48B | |
+4.06% | 40.84B | |
+2.36% | 26.25B | |
+2.07% | 26.48B | |
+12.96% | 24.62B | |
-1.93% | 24.52B |
- Stock Market
- Equities
- ABT Stock